PROVIDER PROFILE · NPI 1013116714

Georgia AljawadiD.O.

PRACTICECLARA LUCKY POLAK MD, INC.See all providers at this practice →

Osteopathic Manipulative MedicineNational City, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

187

Unique beneficiaries

—

Total services

286

Distinct HCPCS

Medicare payment

$24K

Peer benchmark

Total Medicare services vs. 90 Osteopathic Manipulative Medicine providers in CA — below median (cohort median 532).

PRESCRIBING · PART D · 2024

Total Rx claims

5,641

Beneficiaries

—

Total drug cost

$495K

Distinct drugs

Brand share

16.2%

Top prescribed drugs

Atorvastatin Calcium569 claims

Levothyroxine Sodium345 claims

Amlodipine Besylate320 claims

Losartan Potassium295 claims

Lisinopril259 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$700

Payment records

By payment type

Food and Beverage$700

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 050077

Hospital

CCN 050222

Hospital

REFERRAL NETWORK

Where Georgia Aljawadi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Unilab Corporation Clinical Laboratory · West Hills, CA	25	55

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
SCRIPPS HEALTH	33	80
Unilab Corporation Clinical Laboratory · West Hills, CA	23	59
Clara Polak Family Practice · Chula Vista, CA	17	49

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history